Pulse Biosciences (PLSE) vs UFP Technologies (UFPT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pulse Biosciences (PLSE) has outperformed UFP Technologies (UFPT) over the past year, gaining 147.1% versus a gain of 48.7%. Over five years, UFPT leads with a +358.9% price change compared with +126.7% for PLSE. Pulse Biosciences is the larger company by market cap ($3.56 billion vs $2.22 billion), about 1.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PLSE | UFPT |
|---|---|---|
| Share price | $49.98 | $286.56 |
| Market cap | $3.56B | $2.22B |
| 1-day change | +1.81% | -2.15% |
| YTD return | +257.54% | +31.91% |
| 1-year return | +147.06% | +48.68% |
| 5-year return | +126.74% | +358.90% |
| P/E ratio (TTM) | — | 30.95 |
| Forward P/E | — | 24.14 |
| EPS (TTM) | $-1.18 | $9.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $350.00K | — |
| Net income (latest FY) | $-72.78M | — |
| Gross margin | -54.00% | — |
| Operating margin | -21982.57% | — |
| Net margin | -20794.57% | — |
| 52-week high | $58.90 | $338.71 |
| 52-week low | $12.56 | $173.86 |
| Distance from 52-week high | -15.14% | -15.40% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +13.05% | +23.88% |
| Average volume | 506.50K | 157.18K |
| Shares outstanding | 71.32M | 7.75M |
| Employees | 116 | 4,846 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PLSE has outperformed UFPT by 98.4 percentage points over the past year.
About Pulse Biosciences
PLSE stock →Pulse Biosciences, Inc. operates as a novel bioelectric medicine company.
Health Care · Medical/Dental Instruments · 116 employees
About UFP Technologies
UFPT stock →UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing.
Health Care · Medical/Dental Instruments · 4,846 employees
PLSE vs UFPT FAQ
Which is bigger, Pulse Biosciences or UFP Technologies?
Pulse Biosciences (PLSE) is larger, with a market capitalization of $3.56B compared with $2.22B for UFP Technologies (UFPT).
Which stock has performed better over the past year, PLSE or UFPT?
PLSE returned +147.06% over the past 12 months, compared with +48.68% for UFPT (price return, excluding dividends). Past performance does not predict future results.
Are Pulse Biosciences and UFP Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.